A naukri.com initiative
HinduBusinessLine
1w
462
Image Credit: HinduBusinessLine
Anthem Biosciences IPO: Should you subscribe?
- Anthem Biosciences IPO is attracting attention with its positive growth prospects and technology advancements.
- Company operates in CDMO/CRO space providing services from drug discovery to commercialisation with strong efficiency.
- Despite premium valuation, company shows revenue growth and strategic alliances, suggesting potential investor interest.
Read Full Article
8 Likes
For uninterrupted reading, download the app